4DMedical (ASX:4DX) FCF Margin % : -1,882.35% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is 4DMedical FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. 4DMedical's Free Cash Flow for the six months ended in Dec. 2023 was A$-14.93 Mil. 4DMedical's Revenue for the six months ended in Dec. 2023 was A$0.79 Mil. Therefore, 4DMedical's FCF Margin % for the quarter that ended in Dec. 2023 was -1,882.35%.

As of today, 4DMedical's current FCF Yield % is -13.94%.

The historical rank and industry rank for 4DMedical's FCF Margin % or its related term are showing as below:

ASX:4DX' s FCF Margin % Range Over the Past 10 Years
Min: -8292.2 Med: -7025.35 Max: -2689.47
Current: -5602.89

During the past 3 years, the highest FCF Margin % of 4DMedical was -2689.47%. The lowest was -8292.20%. And the median was -7025.35%.

ASX:4DX's FCF Margin % is ranked worse than
97.45% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: -7.14 vs ASX:4DX: -5602.89

4DMedical FCF Margin % Historical Data

The historical data trend for 4DMedical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4DMedical FCF Margin % Chart

4DMedical Annual Data

Trend

Jun21

Jun22

Jun23

FCF Margin %

-7,025.35

-2,689.47

-8,292.20

4DMedical Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial			-12,659.24	-943.43	-1,092.39	8,859.80	-1,882.35

Competitive Comparison of 4DMedical's FCF Margin %

For the Medical Devices subindustry, 4DMedical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

4DMedical's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where 4DMedical's FCF Margin % falls into.

4DMedical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

4DMedical's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-23.384	/	0.282
	=	-8,292.20 %

4DMedical's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-14.927	/	0.793
	=	-1,882.35 %

4DMedical FCF Margin % Related Terms

Thank you for viewing the detailed overview of 4DMedical's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

4DMedical (ASX:4DX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 4DMedical Ltd (ASX:4DX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

FDMDF:USA

Address

700 Swanston Street, Level 7, Melbourne Connect, Carlton, VIC, AUS, 3053

Website

https://www.4dmedical.com

4DMedical Ltd is a company whose principal activities is medical research technology and the development of a non?invasive respiratory imaging solution using four?dimensional imaging. The four-dimensional lung imaging technology utilises mathematics models and algorithms to convert X-ray scans into quantitative data which helps the physicians to manage patients with respiratory diseases and diseases of the lung.

4DMedical (ASX:4DX) Headlines

No Headlines